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Abstract
Background: A recently updated Cochrane systematic review on the effects of lay or community
health workers (LHWs) in primary and community health care concluded that LHW interventions
could lead to promising benefits in the promotion of childhood vaccination uptake. However,
understanding of the costs and cost-effectiveness of involving LHWs in vaccination programmes
remains poor. This paper reviews the costs and cost-effectiveness of vaccination programme
interventions involving LHWs.
Methods: Articles were retrieved if the title, keywords or abstract included terms related to 'lay
health workers', 'vaccination' and 'economics'. Reference lists of studies assessed for inclusion were
also searched and attempts were made to contact authors of all studies included in the Cochrane
review. Studies were included after assessing eligibility of the full-text article. The included studies
were then reviewed against a set of background and technical characteristics.
Results: Of the 2616 records identified, only three studies fully met the inclusion criteria, while
an additional 11 were retained as they included some cost data. Methodologically, the studies were
strong but did not adequately address affordability and sustainability and were also highly
heterogeneous in terms of settings and LHW outcomes, limiting their comparability. There were
insufficient data to allow any conclusions to be drawn regarding the cost-effectiveness of LHW
interventions to promote vaccination uptake. Studies focused largely on health outcomes and did
illustrate to some extent how the institutional characteristics of communities, such as governance
and sources of financial support, influence sustainability.
Conclusion: The included studies suggest that conventional economic evaluations, particularly
cost-effectiveness analyses, generally focus too narrowly on health outcomes, especially in the
context of vaccination promotion and delivery at the primary health care level by LHWs. Further
studies on the costs and cost-effectiveness of vaccination programmes involving LHWs should be
conducted, and these studies should adopt a broader and more holistic approach.
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Background
In 1978, the Alma-Ata Conference put forward the goal of
'Health for all by the year 2000' and declared primary
health care (PHC) the vehicle through which this goal was
to be achieved [1]. As a result, PHC service delivery pro-
grammes using community or lay health workers (LHWs),
a cadre of health worker that was often comprised of ordi-
nary people with minimal health training, were estab-
lished in many low- and middle-income countries
(LMICs) and also became more widespread in high-
income settings [2]. However, a combination of factors
throughout the developing world in the 1980s, such as
economic recession, political and policy changes, popula-
tion growth, poor governance, and inadequate health sys-
tems, led to reduced investments in primary health care,
including in LHW programmes [2,3]. Today, a key chal-
lenge of health systems in many countries is the need to
develop and strengthen human resources to deliver essen-
tial interventions [4,5]. This has been a key factor in rekin-
dling interest in the use of LHWs [6,7].
In 2005 Lewin et al. [8] published a Cochrane systematic
review examining the global evidence from randomized
controlled trials (RCTs) on the effects of LHWs pro-
grammes, as compared to usual primary and community
health care. This review indicated promising benefits, in
comparison with usual care, for LHW interventions in the
areas of vaccine promotion; breastfeeding promotion and
treatment for selected infectious diseases. However, these
results were based only on a limited number of studies.
For example, the review identified only three RCTs exam-
ining the effectiveness of LHW programmes in improving
vaccination uptake. An update of the original review by
Lewin et al. [8] to identify and synthesize the results of
more recent studies on LHW programmes is being under-
taken. An interim report on the updated review identified
six trials of vaccination promotion by LHWs [9].
With its focus on RCTs of effectiveness, the original review
[8] did not explore factors influencing the costs and cost-
effectiveness of LHWs in delivering health services such as
vaccinations. Taking intervention costs and effectiveness
considerations into account is important for policy deci-
sions and concerns around the affordability of resource
inputs for health worker programmes. For governments
and funding agencies, the question of whether an inter-
vention is more or less cost-effective compared to alterna-
tive interventions, as well as whether there are sufficient
funds to pay for the intervention, are factors that influence
decision-making. Part of the growing interest in LHW pro-
grammes is related to the perception that they are cheaper
than those that use professional health staff. However, a
health programme is defined as affordable only if each
individual or organization financially contributing to the
programme is willing and able to contribute to financing
its operation on the scale envisioned in the programme
design [10]. A greater problem in health programming,
from the perspective of those funding these initiatives, is
the widespread failure to analyze the future recurrent cost
implications of a proposed investment programme and to
assess whether these costs will be affordable given availa-
ble financing sources [10].
These considerations have practical implications for eco-
nomic evaluations of health worker programmes, and
specifically LHW programmes. Generally, conventional
economic evaluations, particularly cost-effectiveness anal-
ysis, focus narrowly on health outcomes, and do not take
into account the role of human-made institutions in shap-
ing economic behaviour. Nor do current economic evalu-
ation methods capture social non-health benefits, such as
community empowerment and higher social capital,
which may have positive or negative values, and are
related to programme-induced changes in the wider com-
munity [2]. Through their overly reductionist perspective,
conventional economic evaluations of LHW programmes
are ill-equipped to deal with institutional changes [11],
such as changes in local governance or differences in
social values, which are especially important at the com-
munity-level. Institutional economics, alternatively, con-
siders the social norms and networks which govern
individual and group behaviour and are an important
dimension to consider when looking at the cost-effective-
ness of LHW programmes. For example, the training of
programme staff and other activities that are seen as insti-
tution-building, with benefit flows beyond the duration
of the programme, are treated as a resource input when
valuating outcomes. However, within an institutional
economics framework, they may also be considered an
intermediate output, with its entire cost subject to amorti-
zation as per capital costs [11].
Two non-systematic reviews have indicated the general
dearth of cost-effectiveness data on LHW programmes
[2,12]. Similarly, three systematic reviews focussing on
LMICs, one on the effects and costs of expanding immu-
nisation strategies [13], the other a systematic review of
the grey literature on strategies for increasing coverage of
routine immunisations [14], and the third a review of
published and grey literature on routine immunisation
[15], demonstrated the paucity of cost-effectiveness data
on strategies to expand the coverage of vaccination serv-
ices in developing countries. What continues to be miss-
ing, however, is a targeted review of the costs and cost-
effectiveness of involving LHWs in vaccination pro-
grammes. As part of a wider study on LHW programmes
for vaccination uptake in low- and middle-income coun-
tries (LAYVAC), a systematic review of the costs and cost-
effectiveness of using LHWs to promote or deliver vacci-
nations was conducted.Human Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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The overall aim of this paper was to review the costs and
cost-effectiveness of vaccination programme interven-
tions involving LHWs. This paper sought to:
1. Identify studies which evaluate the costs and cost-effec-
tiveness of vaccination programme interventions involv-
ing LHWs;
2. Summarize included studies narratively and evaluate
them according to a methodological quality checklist;
3. Identify factors that contribute to the costs and cost-
effectiveness of LHWs and vaccine interventions, and
examine how theories of institutional economics can con-
tribute to understanding the costs and cost-effectiveness
of LHW programmes.
Methods of the review
Selection criteria
This study used Lewin et al.'s [8] definition of a LHW as
any health worker carrying out functions related to health
care delivery; trained in some way in the context of the
intervention, usually informally and related to the job;
and having no formal professional or paraprofessional
certificate or degree-conferring tertiary education. The
term 'LHW' is thus necessarily broad in scope and
includes providers involved in both paid and voluntary
care. For this review, any type of LHW (paid or voluntary)
was included, such as community health workers, village
health workers, cancer supporters, birth attendants and
medical auxiliaries. Studies on vaccination programmes,
be they linked to health promotion activities, vaccine
delivery, etc., for both children and adults were included.
Full economic evaluations were defined according to
Drummond et al.'s [16] definition as 'the comparative
analysis of alternative courses of action in terms of both
their costs and consequences.' No economic evaluation
designs were excluded. Studies involving LHWs and vacci-
nation programmes and including any costing informa-
tion were included for secondary analysis of LHW
activities and costs. Studies in languages other than Eng-
lish, Spanish or French were excluded.
Search strategy for study identification
The following electronic databases were searched: NHS
EED Cochrane Library (Issue 1 2008); NHS-EED Center
for Reviews and Dissemination (to February 2009);
MEDLINE (1950-February 2009); CINAHL (1982-
December 2007); EMBASE (1980 to February 2009); ISI
Web of Science (1975 to February 2009); EconLIT (1969
to February 2008); Health Economic Evaluation Database
(HEED) (to February 2008); LILACS (Latin American and
Caribbean Health Sciences Literature) (to January 2008);
African Index Medicus (AIM) (to February 2008); Western
Pacific Region Index Medicus (WPRIM) (to February
2008); Index Medicus EMRO (Eastern Mediterranean) (to
February 2008); SSRN (Social Science Research Network -
- Economic Research Network) (to February 2008).
Search criteria
Full text copies of all articles that were identified as poten-
tially relevant by either reviewer were retrieved. Each full
paper was assessed independently for inclusion by at least
two reviewers. When reviewers disagreed the decision was
referred to a third reviewer.
The searches included a combination of vaccination, LHW
and economic terms. Additional file 1 provides the full
details of the search strategy for Medline. Details of strat-
egies for the other databases are available from the
authors on request. Reference lists of studies assessed for
inclusion were also searched. Reviews by Walker and Jan
[2] and Pegurri et al. [13] were used to identify potential
studies for inclusion; monographs, technical reports and
books were excluded as this review focused on published
articles. The authors of all studies included in the update
of the Cochrane review by Lewin et al. [8] were contacted
to ask whether they had collected costs or conducted cost-
effectiveness analyses alongside their study. Authors of
studies that met initial screening criteria and where fur-
ther clarification was needed were also contacted. Studies
were included after screening of the full-text article.
Review criteria
The papers were reviewed using a series of questions based
on Pegurri et al. [13], which were adapted slightly to
reflect some important aspects of working with LHWs, e.g.
level of training, remuneration, sustainability, etc. The
review questions were split into two parts: background
characteristics and technical aspects (Appendix 1). The
aim of these questions was twofold: first, to establish the
basis for a descriptive analysis of published evidence and
second, to enable a structured evaluation of the studies.
Results
There were 2616 records identified. Eighty-four of these
studies were considered potentially eligible for inclusion
and full text articles were then retrieved. Five additional
studies were known to the authors or identified from
hand-searching references of key studies and reviews once
the full-text articles were retrieved, giving a total of 89 arti-
cles. Three studies fully met the inclusion criteria of an
economic evaluation of a vaccination programme involv-
ing LHWs, while an additional 11 were retained as they
included some cost data associated with a vaccination
programme involving LHWs. Four authors were contacted
for papers on the basis of their conference abstracts; how-
ever, the papers were not available for inclusion in this
study. All included studies were published in English orHuman Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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Spanish language journals. The results of the search are
shown in Figure 1 (QUORUM flow chart).
Given the small number of full economic evaluations
identified, the following section provides a short descrip-
tion of each. All costs were reported in US dollars (except
where noted) and are reproduced here as originally stated
in the respective studies (see Table 1 and Additional
file 2).
Deuson et al. [17] assessed the value for money of a com-
munity-based Hepatitis B vaccination catch-up project for
4384 Asian American children in Philadelphia, USA,
implicitly compared with usual care. Staff in the commu-
nity-based organizations acted as LHWs through educat-
ing parents about the hepatitis B vaccination and visited
homes of children due for a vaccine dose. Costs per child,
per dose, and per completed series were $64, $119, and
$537, respectively while the cost per discounted year of
life saved was $11 525.
San Sebastian et al. [18] compared the costs and outcomes
of two different vaccination strategies for children under
five years of age between 1993 and 1995. The District
Hospital (DH) strategy was centrally planned and man-
aged by the DH and fully vaccinated five children, result-
ing in a cost of $777.60 per vaccinated child. The
community health worker (CHW) strategy was planned
and implemented in conjunction with the CHW Associa-
tion and fully vaccinated 113 children at a cost of $32 per
child.
Weaver et al. [19] conducted an economic evaluation of a
community-based outreach initiative to promote pneu-
mococcal and influenza vaccines for people aged over 65
years, compared with no outreach. The authors found that
the cost per quality-adjusted life year (QALY) gained was
$35 486 for the combined outreach initiative, $53 547 per
QALY for the pneumococcal vaccine and $130 908 per
QALY for the influenza vaccine. The cost-effectiveness
ratio of the intervention targeted to people who had never
received the influenza vaccine the previous year was $11
771 per QALY.
The remaining studies did not fulfil the definition of a full
economic evaluation but contained some data on the vac-
cination- and human resource-related costs of vaccination
programmes. Of these, four studies looked at LHWs deliv-
ering vaccinations only [20-23], five studies evaluated
LHWs to promote vaccinations [24-28] (including can-
vassing, publicizing and persuading people to get vacci-
nated), and two studies reported using LHWs for both
promotion and vaccination [29,30]. Comparing costs in
any meaningful way was difficult due to the differences in
outcome reporting. More in-depth descriptions of these
studies can be found in Additional file 3.
Background characteristics of the included studies
The included cost-effectiveness studies were diverse in
terms of the contexts in which they were conducted and
the roles of the LHWs in these settings (see Table 1). The
settings of the included cost-effectiveness studies ranged
from urban centres in the United States of America, such
as Philadelphia [17] and Seattle [19], to sparsely popu-
lated communities living along the Ecuadorian jungle
river system [18]. LHW vaccination activities included the
promotion of Hepatitis B vaccine uptake [17]; routine
immunisation [18] amongst children; and the promotion
of pneumococcal and influenza vaccination amongst
individuals over the age of 65 [19].
The settings of the studies that included some cost data
related to vaccination programmes were also very diverse.
Of these 11 studies, 10 took place in low- and middle-
income countries (Bangladesh [22], Brazil [24], Egypt
[30], Haiti [21], India [26], Indonesia [23], Mexico [29],
Mozambique [25], Pakistan [20]), and also in West Bank
and Gaza Strip [28], while the remaining study discussed
the role and costs associated with immunisation registries
and follow-up reminders by LHWs for full vaccination
coverage in the United States of America [27].
This review also shows highly disparate uses of LHWs
(Table 1 and Additional file 2). This ranges from the com-
munity-level health worker, with very basic training in
delivering preventive health services such as vaccinations
at the household level [18,28,30] or outdoor markets
[21], to the use of volunteers to promote vaccination
uptake amongst those over 65 years of age [19] or door-
to-door [25]. Overall, the LHWs in the included studies
were used mainly to link communities to vaccination
delivery through promotion or campaigns.
Governance issues and institutional characteristics
emerged as important factors in determining LHW roles.
For example, San Sebastian et al. [18] noted that in the
Amazon district of Low-Napo, where their LHW interven-
tion strategy took place, an outreach strategy is required to
reach the indigenous population living scattered along
rivers, where immunisation coverage is especially low.
Compared to the centrally-planned and district hospital
implemented vaccination program strategy, the strategy
that was planned and implemented with local LHWs was
far more effective and successful. LHWs residing in the
area are trained to vaccinate as part of their commitment
to a PHC programme, and provide nearly half of all out-
patient care in the Napo river area. However, their efforts
and labour are not always recognized by policy officials
[18], which are part of the more formalised institutional
and governance structure. In Mexico, researchers found
that there were cost-savings when community vaccinators
with basic nurse training were used to vaccinate, as com-
pared to the usual delivery of care [29]. They attribute thisHuman Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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to factors such as having the same vaccinators within their
geographic area of responsibility; constant interaction
without conflict between the vaccinator and the commu-
nity; and allowing the vaccinators the freedom to choose
the day and time for home visits.
Recognizing where LHWs can add value in delivering
healthcare services, and clearly defining LHW roles and
responsibilities is important. In their study in the West
Bank and Gaza Strip, Tulchinsky et al. [28] suggest that the
village health worker as an all-purpose health provider
may be difficult to supervise and sustain. Others have
noted that using village health workers for a more selec-
tive set of services may be more feasible and manageable
when trying to achieve specific targets in disease control
[31]. This calls to mind the decades-long debate surround-
ing 'comprehensive primary health care' versus 'selective
primary health care.' Whereas 'comprehensive primary
health care' is concerned with a developmental process by
which people improve both their lives and life-styles,
'selective primary health care' is concerned with medical
interventions aimed at improving the health status of the
most individuals at the lowest cost [32]. Narrower or
more selective primary health care interventions are easier
to evaluate from a conventional economic perspective
but, as noted above, such approaches may fail to capture
the wider social and institutional changes that may follow
these programmes.
Methodological characteristics
The methodological quality of the included three full eco-
nomic evaluation studies was good (see Table 2). The
viewpoint was explicitly stated by Deuson et al. [17] and
could be inferred in the others, with a societal perspective
being taken in each case. That is to say, the analyses
included all benefits and costs of the programme regard-
less of who received or paid them, respectively. All impor-
tant and relevant inputs were identified and valued, with
data sources clearly identified. All three studies included
economic costs and reported results of sensitivity analy-
ses. Though authors compared their studies to previously
published research in order to contextualize their find-
ings, this was insufficient to provide any useful basis for
generalizing their findings across time and space.
There were fundamental differences in these three studies
in terms of:
• variations in context, including differences in setting
and location (Philadelphia [17] versus Amazonian
Ecuador [18] versus Seattle [19]);
￿ comparator used (doing nothing [17,19] versus a
second strategy [18]);
￿ intervention design (costs-effectiveness analysis of
an education and outreach programme for Hepatitis B
vaccination [17], cost-effectiveness analysis of two
routine childhood vaccination programmes [18], and
a cost-effectiveness analysis conducted alongside a
randomized, controlled trial of a community-based
outreach initiative [19]);
￿ outcomes measured (costs per child receiving any
dose, per dose delivered, per completed series, and per
additional child rendered sero-protected [17]; cost per
fully vaccinated child [18] and costs per total QALYs
lost because of vaccine side effects, morbidity, and
mortality [19]);
￿ and study populations (Asian American children
aged 2--13 years [17]; children aged 0--5 years [18];
and seniors aged 65 and older [19]).
There were some similarities in the times that were costed,
but also significant differences between studies in the
items that were included. In addition, the same items were
costed differently across the three studies, mainly based
on their intervention and context-specificity.
QUORUM flow chart Figure 1
QUORUM flow chart.
2616  Articles or abstracts identified initially through title, abstract and/or keyword 
screening
89  Articles identified, including those found from hand-searching references of selected 
studies and reviews, and those known to the authors 
60 Articles  retrieved
13  Excluded based on their abstract or language 
6  Excluded as they were monographs or technical reports 
6  Could not be found or retrieved 
4  Removed after abstract authors contacted: studies not ready for publication 
17  Did not meet study inclusion criteria 
3 Full economic evaluations + 11 Costing studies Human Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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￿ Direct costs: All three studies included vaccine sup-
ply costs; however, while Deuson et al. and San Sebas-
tian valued volunteer salaries at unskilled wage rates,
Weaver et al. calculated hourly volunteer time by the
mean weekly earnings of people aged 65 years and
over, divided by 40 (based on a 40-hour work week).
Deuson et al. and Weaver et al. included computerized
tracking system costs, managing side effects, and hos-
pitalization, and San Sebastian also counted fuel and
maintenance costs and per diem allowances. The cost
items continued to diverge, as Deuson et al. included
inpatient, outpatient, scanner, and laboratory costs for
acute and chronic HBV infection, and Weaver et al.
included volunteer training costs.
￿ Indirect costs: the time spent by caregivers on vacci-
nation and travelling, as well as volunteer LHW trans-
portation time, were included and valued at the
unskilled wage rate (San Sebastian, Weaver et al.),
while medical visits and loss of earnings due to illness
were accounted for by Deuson et al.
￿ Excluded costs: capital costs (land, buildings, shared
equipment and administration) and other costs com-
mon to the intervention and the comparator were
excluded by all studies.
Both the comparability of the findings of these studies
and their wider generalizability is hindered by these fac-
tors. We address this point in greater detail in the discus-
sion.
Worryingly, issues of vaccination programme affordabil-
ity and sustainability were largely ignored, though one
study [17], noting the increasing administration of vac-
cines by the private sector, explored the impact of using
private sector prices in delivering the intervention. In this
study, only the cost of the vaccine, which comprised 8.7%
Table 1: Background characteristics of the full economic evaluations
Deuson et al. [17] San Sebastian et al. [18] Weaver et al. [19]
Area studied Philadelphia, USA Low-Napo area in Napo province, 
covering 300 km of the Napo river
Seattle, USA
Timing of the study October 1994 - February 1996 1993-1995 October- November 1996
Type of intervention Promotion prior to a catch-up 
campaign1
Campaign Promotion
Type of LHW/role of LHW Staff of community-based 
organisation
CHWs* Senior volunteers, i.e. older people
Training Unstated 3-year training in preventive 
medicine, including immunisation, 
and curative activities
Received training about the 
pneumococcal and influenza vaccines 
and received technical support from the 
project coordinator.
Comparator(s) (Implicitly) Doing nothing Centrally planned strategy (District 
Hospital strategy) of immunizing 
children <1 year
(Implicitly) Doing nothing
Study type CEA & CUA CEA CEA
Vaccines delivered Hepatitis B Routine childhood vaccines Pneumococcal and influenza vaccines
Age group(s) targeted 2-13 year-olds 0-5 years-old 65 years +
Perspective(s) Societal Societal Societal
$ per child vaccinated Costs per child, per dose, and per 
completed series were $64, $119, 
and $537, respectively
$32 per FVC Not stated
CE results The cost per discounted year of life 
saved was $11,525 and the benefit-
cost ratio was 4.44:1
CHW intervention dominated the 
District Hospital comparison
Intervention cost $35,486/QALY gained 
for the combined outreach initiative, 
$53,547/QALY for the pneumococcal 
vaccine and $130,908/QALY for the 
influenza vaccine. For seniors who had 
never received a vaccine, the combined 
outreach initiative cost $11,771/QALY 
gained, $38,030/QALY for the 
pneumococcal vaccine, and $22,431/
QALY for the influenza vaccine.
Funded by Centers for Disease Control 
(CDC), USA
Medicus Mundi Andalucia, Spain CDC
* Local indigenous organization started a PHC programme in 25 communities with training of CHWs. Each community has two CHWs with 3 year 
training in preventive medicine, including immunisation and curative activities. CHWs are literate and elected by their own community and receive 
no financial reward.
1 Catch-up campaign: targeted efforts to vaccinate individuals that did not receive the vaccine that they would otherwise have received through 
routine immunisation
Campaign: targeted efforts of vaccinating a group of and/or a pre-determined number of individuals for vaccinationHuman Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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of the total cost of the programme, was varied and other
costs, such as community education, outreach and plan-
ning, were not [17]. Sustainability issues are discussed in
greater detail below.
Discussion
Despite keeping the inclusion criteria broad and general
for sensitivity purposes, and despite systematically search-
ing a large number of databases, there was a dearth of
published economic evaluations of LHWs in vaccination
programmes. Recently published studies point to the
potential expansion of LHW involvement in vaccine deliv-
ery, especially related to the latest vaccine-related techno-
logical innovations, such as thermostable vaccines [33]
and Uniject devices [23]. Combined with the emerging
trend of adding more services to immunisation cam-
paigns (e.g. vitamin A, insecticide-treated nets, etc.), we
may see more studies reporting the use of LHWs in the
future.
The results of the three economic evaluations included in
the systematic review show that LHWs were more cost-
effective options than the comparator, which did not
include LHWs. However, given the diversity in the popu-
lation groups targeted, as well as in the types of interven-
tions and settings, it is difficult to draw generalizations
from these studies. For example, Weaver et al. [19] found
that targeting interventions to people who had never
received the pneumococcal vaccine or who had not
received the influenza vaccine in the previous year
improved cost-effectiveness, while Deuson et al. [17]
focused on increasing coverage of Hepatitis B vaccination
for first-generation children of Asian and Pacific Islander
descent, aged between two and 13 years.
The inclusion criteria for this review excluded studies not
mentioning lay health workers, vaccines or economic
evaluations, or terms related to these. Studies were
included when they specifically mentioned LHW involve-
ment in vaccination alongside other health services and
indicated costs [26,28]. However, we may have excluded
a body of economic evaluation literature concerning the
delivery of vaccinations in which LHWs were involved,
but packaged with other targeted health services such as
family planning interventions. Simmons et al. [34], for
example, evaluated the cost-effectiveness of family plan-
ning research programmes delivered by LHWs in rural
Bangladesh as compared to government programmes;
they indicated that vaccines comprised 0.12% of the total
programme budget from 1978-1985.
Vaccine delivery by LHWs can be characterized as a com-
plex intervention, whose components usually include
behaviours, parameters of behaviours (e.g. frequency,
timing) and methods of organizing and delivering those
behaviours (e.g. type(s) of practitioner, setting and loca-
tion); the number of groups or organizational levels tar-
geted by the intervention; and the number and variability
of outcomes [35]. To add to the complexity, vaccination
programmes are bundled increasingly with other health
campaigns, offering a challenge in determining the cost-
effectiveness of the immunisation component. For exam-
ple, a recent cost-effectiveness analysis was conducted of
insecticide-treated net (ITN) distribution as part of the
Table 2: Quality checklist (Yes/No/Not Clear/Not stated/Not applicable)
Deuson et al. [17] San Sebastian et al. [18] Weaver et al. [19]
1 Was the viewpoint explicitly stated? No, but could be inferred No, but could be inferred Yes
2 Were all the important and relevant inputs 
identified and valued given the viewpoint?
Yes Yes Yes
3 Were sources of data clearly identified? Yes Not stated Yes
4 Were the unit costs of inputs and quantity 
clearly identified?
No Yes No
5 Was it clear how costs were valued? Yes Yes Yes
6 Is there an attempt to calculate economic 
costs?
Yes Yes Yes
7 Were base year, details about currency 
conversion and any adjustment for inflation 
given?
Yes Yes to base year and currency conversion. 
No indication of adjustment for inflation.
No
8 Was discounting performed? Yes No Yes
9 If yes, was an appropriate justification of 
the rate given?
Yes NA Yes
10 Was sensitivity analysis performed? Yes Yes Yes
11 If yes, were justifications for the choice of 
variable and their level given?
Yes No Yes
12 Were issues of affordability and/or 
sustainability discussed?
No No No
13 Was generalizability discussed by the 
authors?
Yes, but not sufficiently Yes, but not sufficiently Yes, but not sufficientlyHuman Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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2004 measles vaccination campaign in Togo, with shared
costs assumed to be equally attributed between the two
health interventions [36]. The results suggested that sub-
stantial efficiency gains may be derived from the joint
delivery of vaccination campaigns and malaria interven-
tions [36]. Because it is rare for vaccinations or other
health services to be delivered in isolation from one
another, it is often difficult to determine the indirect costs
associated with immunisations in particular. As can be
seen by the paucity of full economic evaluations of LHWs
and vaccination found in this review, it is also difficult to
evaluate the costs associated solely with LHW involve-
ment, mainly due to the interaction of various types of
health personnel in service provision. For example, an
evaluation of house-to-house versus fixed-site oral polio
vaccine delivery strategies in a mass immunisation cam-
paign in Egypt included the costs of physicians, nurses,
hygienists, clerks and drivers, in addition to community
workers, with differences in personnel costs not only
linked to fixed-site versus house-visit, but also linked to
urban versus rural areas [30]. Therefore it is difficult, if not
impossible, to tease out the contribution of the LHWs.
Like effectiveness outcomes, the costs of (complex) inter-
ventions can be strongly determined by contextual factors;
by the exact combination and 'dose' of intervention com-
ponents; or by the behavioural predispositions of partici-
pants or providers. A population's attitude toward health
care and interventions, compliance and adherence, utility
valuations of health status, and incentives---such as level
of co-payment---are also important components that can
have a significant impact on cost-effectiveness [37]. The
difficulty in generalising or transferring economic evalua-
tion results to other settings arises because we do not
know what caused the particular relationship between
opportunity costs and outcomes in each instance. As inter-
ventions become more complex, it becomes even more
difficult to explain how a specific bundle of intervention
components (and their associated resource use), provided
in a given context, has generated the levels and types of
outcomes measured [38,39].
LHWs and institutional economics
The presence of LHWs, and the sustainability of their
efforts, also relate to the institutional characteristics of a
community. Institutions and institutional characteristics
are here defined as the 'rules that govern the conduct of
individuals, groups and organizations' [11] and, related to
this, the 'patterns of behaviour that determine how indi-
viduals, groups and organizations interact with one
another' [40]. Institutional economics addresses the role
of human-made institutions in shaping economic behav-
iour, with the understanding that economic analyses and
understanding should also consider the political and
social system within which economics is embedded.
One of the included studies provides an example of these
processes: ongoing demand for the Village Health Room
programme between 1985 and 1996 in the West Bank and
Gaza Strip overcame political conflict and strains on the
delivery of public services, due to both strong community
support from the communities served by village health
guides and positive recognition by Palestinian health
authorities [28]. And, as was noted by San Sebastian et al.
[18], involving communities in the planning and imple-
mentation of vaccine delivery in the sparsely populated
Low-Napo area in Ecuador using the CHW strategy, rather
than a top-down district hospital strategy, created com-
munity ownership and accountability of the programme,
and maximized the cost-effectiveness of immunisation.
However, in these cases, conventional economic evalua-
tions failed to capture the 'instrumental value' [11] of
LHWs to the community, such as the changes in commu-
nity norms that may encourage the initiation of further
activities and the provision of further services. Further-
more, economic evaluations did not take into account the
potential reduction in transaction costs resulting from the
LHW being a recognized member of the community,
which in itself provides social capital and reduces the
amount of time required, as well as the need, to develop
new social networks, trust and access to community's
resources.
Another example where conventional economic evalua-
tions fail to capture wider, context-specific characteristics
is the issue of volunteerism. Within the context of LHWs
and vaccine delivery in this review, for example, we found
that two studies depended on volunteers for vaccine pro-
motion and uptake [18,19] while the other studies paid
the LHWs. The programme intervention of Weaver et al.
[19] used a paid programme coordinator, but their strat-
egy also depended heavily on unpaid volunteers. Volun-
teer labour and paid labour are often used
interchangeably, under the assumption that shadow
prices for volunteer labour can be substituted for market
wages, such as unskilled wage rates [2,16], and the
assumption that volunteer and paid staff are equally pro-
ductive [41]. However, volunteerism, like other forms of
labour, is often determined by a different set of personal
and social characteristics, and may not be broadly socially
patterned or systematic [42]. Furthermore, a community
that produces a supply of individuals willing to volunteer
may be different to one that does not [2].
Economic evaluations can incorporate such institutional
factors by taking a more holistic approach that captures
the contribution of health services to the wider commu-
nity through paying attention to wider community char-
acteristics and impacts. This involves understanding
ongoing changes in the ways in which individuals, groups
and organizations relate to one another and the full extentHuman Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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of downstream transaction costs [43]. A strong compo-
nent of the underlying argument for the Alma Ata declara-
tion on primary health care (PHC) thirty years ago, and its
emphasis on strengthening health care delivery within a
wider definition of health, was that health sector interven-
tions, such as using LHWs for vaccine delivery, can effect
institutional changes. As PHC reflects and evolves from
the economic conditions, socio-cultural and political
characteristics of a country and its communities, and is
based on the application of the relevant results of social,
biomedical and health services research and public health
experience [44], it is critical for economic evaluations of
PHC-related activities to include an institutionalist com-
ponent.
Sustainability of LHW programmes
Tied to these institutional factors are issues surrounding
the sustainability of LHW programmes. Sustainability
refers to the continuing ability of a project to meet the
needs of its community [45], beyond the period of an
intervention [46]. When assessing sustainability, it is use-
ful to differentiate between the sustainability of measured
effects, which is difficult to assess when programmes are
evaluated for only a few months; the sustainability of the
programme's interventions, regardless of its effects (our
focus here); and continued financial viability, which is
linked to the programme sustainability. Gruen et al. [47]
propose that sustainable health programmes be regarded
as complex systems that encompass the programmes
themselves, the health problems targeted by these pro-
grammes and the programmes' drivers or key stakehold-
ers, all of which interact dynamically within any given
context. In their systematic review of studies associated
with health-programme sustainability, they identified a
wide range of factors, including context and resource
availability, amongst others [47]. Shediac-Rizkallah and
Bone [48] and Bossert [49] note that factors that affect sus-
tainability include programme design, organizational
aspects, and contextual attributes including local health
policy and social, cultural, and environmental characteris-
tics. As programme sustainability is strengthened by input
and support from all facets of the community, this may be
linked to the costs that the community and country can
afford to maintain, the stage of their economic develop-
ment, and the importance of community self-reliance and
self-determination [50].
The full economic evaluations identified in this review
evaluated programmes over a period of two months [19],
18 months [17,19,27] and two years [18]. The costing
studies were evaluated over an average of nearly four years
(range: nine months [29] to 11 years [28]). Furthermore,
in the full economic evaluations, the LHWs were evalu-
ated as part of vaccination promotions or a vaccination
campaign, as compared to usual delivery of care, and thus
could be perceived as not necessarily being embedded
within the health system.
The one study which addressed the issue of sustainability
had the longest lifespan of all of the studies, operating for
over a decade in the West Bank and Gaza Strip [28]. In this
project, the LHWs were young, local women with 10-11
years education, who underwent 6-8 months of training
and were paid stipends for their work. They had high lev-
els of prestige in the village and were recognized as an
integral part of a health system, as well as being closely
supported and supervised by the health system. Issues of
sustainability were explored through recognizing the
importance of funding, political and administrative sup-
port and especially continuity among the guides and
supervisory personnel during various transition periods of
the programme -- from external funding, to inclusion
within the Government Health Services after initial fund-
ing ended and in the transition between Israeli and Pales-
tinian administrations. Expansion efforts in 1994 were
credited to strong community support for the programme
in the villages served and its recognition by Palestinian
health authorities.
As this review illustrates, the data available in most cost
and cost-effectiveness studies of LHW programmes for
vaccination do not allow any rigorous assessment of effect
sustainability, programme sustainability or financial sus-
tainability. While these aspects are often difficult to assess
within a research framework, given time and resource lim-
itations, they are typically of great interest to decision
makers. Researchers therefore need to pay greater atten-
tion to assessing the sustainability of the interventions
studied and to developing robust methods for evaluating
this.
Conclusion
In his review 'Systematic reviews of economic evaluations:
utility or futility?', Anderson argues that it has become
increasingly recognised in public health and health pro-
motion that only asking whether an intervention "is effec-
tive" has limited value, because effectiveness is more
complex and contingent on the specific combination of
elements in an intervention, and/or its interaction with
different community and organisational contexts [51].
Rather, he argues, it makes much more sense to ask "how
and why" an intervention is or is not effective or cost-
effective in different circumstances. As noted by Drum-
mond, "there is widespread recognition amongst econo-
mists, and possibly amongst decision makers, that
whether or not a particular intervention is cost-effective
depends on the local situation" [16]. However, a common
characteristic of economic evaluation studies in health-
care is that though sensitivity analyses are undertaken to
deal with uncertainties in the models, few studies lookHuman Resources for Health 2009, 7:81 http://www.human-resources-health.com/content/7/1/81
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explicitly at variability between locations [37], let alone
attempt to explain how different levels of resources con-
tribute to different levels and combinations of outcomes.
This review highlights the dearth of LHW vaccination
strategies that have been evaluated on an economic basis.
The very small number of studies identified that evaluated
the economic aspects of LHWs promoting or delivering
vaccination, as well as the heterogeneity of these studies,
makes it difficult to draw conclusions on whether the use
of LHWs in vaccination programmes represents good
value for the resources invested. The lack of studies is
especially surprising given that vaccination is one of the
most cost-effective public health interventions [52] and
that vaccination comprises a basic component of primary
health care and comprises a key part of Millennium Devel-
opment Goal 4 [53].
It is conceivable that with a larger number of economic
evaluations than these three studies, specific characteris-
tics of LHWs in vaccination programmes that could be
generalized to help inform decision making would have
been identified. The current lack of standardization in the
design, analysis and reporting of results from economic
evaluations, and substantially different outcomes [54],
also lead to a lack of comparability. In this review, out-
comes of the included studies were: cost per discounted
year of life [17], cost per fully vaccinated child [18] and
cost per quality adjusted life year [19]. Though there is a
role for peer review to play in upholding and regulating
reporting standards for the economic evaluations pub-
lished [55], as well as in the quality of the studies pub-
lished, there is also a need for more consistency in
adhering to the numerous recommendations and guide-
lines for conducting economic evaluations [16,56]. This,
in turn, would aid the potential of systematic reviews to
provide insights for planning and decision making.
Further research on the costs and cost-effectiveness of
LHWs in delivering and promoting vaccinations is needed
(Table 3), especially with closer examination of: the links
between LHW-roles and strengthened primary-care facili-
ties and first-referral services [3]; potential LHW involve-
ment in long-term human resource planning; better
training and supportive supervision [57]; the substitution
of nursing and other professional tasks by lay workers
Table 3: Recommendations for future research
To provide decision makers with adequate and useful data on the cost effectiveness of lay health worker interventions for vaccination, future 
evaluations of such programmes should:
Compare the costs of alternative options • include a comparative analysis of costs and consequences of alternative 
courses of action, or at least a detailed costing of personnel and other 
resources associated with the intervention
Standardize design, analysis and reporting ￿ address the current lack of standardization in the design, analysis and 
reporting of economic evaluations results; in the range of outcomes 
used; and in the reporting of contextual factors, to improve the 
comparability of these evaluations
Examine the variability of interventions ￿ look explicitly at variability between interventions implemented in 
different locations (within or between countries) and explore how 
different levels of resources contribute to different levels and 
combinations of outcomes
Explore types and levels of remuneration ￿ explore how different levels and methods of remuneration, and types 
of financial or non-financial incentives, impact on the cost-effectiveness 
and sustainability of programmes
Vary the evaluation time frame ￿ explore the impacts on cost-effectiveness of incorporating a longer 
evaluation time-frame
Capture the instrumental value of LHWs to the communities in which 
they work*
￿ assess the impact on cost-effectiveness of using an institutional 
economics framework, such addressing issues of implicit contracts and 
informational asymmetries; taking into account governance issues and 
institutional evolution and transition; and conducting a transaction cost 
analysis
￿develop approaches to account for volunteer labour in these 
programmes
* Jan S, Pronyk P, Kim J: Accounting for institutional change in health economic evaluation: a program to tackle HIV/AIDS and 
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(e.g. CHWs, pharmacy assistants) [3]; and cost-effective
approaches to determining the allocation of PHC services
based on health needs [3]. Concomitant with technologi-
cal advancements in improving the safety, efficiency and
thermostability of vaccinations, assessments should be
conducted as to how LHWs may provide an increasingly
important role in vaccine delivery at the community level.
Building on these recommendations, it is proposed that
this area of research would also benefit strongly from a
randomized community trial, or series of trials, compar-
ing the cost-effectiveness of LHWs for vaccination in a
range of low-, middle- and high-income settings. It is
important to adhere to existing guidelines for the conduct
of cost-effectiveness studies and to build on these by using
the holistic economic evaluation framework proposed by
Jan et al. [11]. This would aid in incorporating aspects of
institutionalist economics, which takes into account con-
text-specific norms and values, and better reflects the
wider social value of health programmes within a com-
munity. Further to this, taking into consideration sustain-
ability issues will help ensure continuing programme
responsiveness to community needs, and allow LHWs to
maximise their effectiveness in the context in which they
are working.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SL, IS and CG conceived of the study. AC and DW
designed the study, conducted the search and analysis,
interpreted the data, and drafted the manuscript. All
authors read and approved the final manuscript.
Appendix 1 - Criteria for evaluation
- Was the perspective from which the costs were measured
explicitly stated?
- Were all the important and relevant inputs identified
and valued given the viewpoint?
- Were sources of data clearly identified? (list sources)
- Were the unit costs of inputs and quantity clearly identi-
fied?
- Was it clear how costs were valued?
- Is there an attempt to calculate economic costs?
- Were base year, details about currency conversion and
any adjustment for inflation given?
- Was discounting performed? If yes, was an appropriate
justification of the rate given?
- Was sensitivity analysis performed? If yes, were justifica-
tions for the choice of variable and their level given?
- Were issues of affordability and/or sustainability dis-
cussed?
- Was generalizability discussed by the authors?
- Were transaction costs, or transaction cost savings, esti-
mated?
- Were community norms or values discussed in the con-
text of the institutionalization of LHW programmes?
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